Harmony Biosciences Holdings, Inc. Cash Flow Statement

Cash Flow Statement Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -119.47M-30.53M30.94M181.47M115.43M117.49M
Depreciation and Depletion 0.40M0.39M0.42M0.42M0.51M0.27M
Share-based Compensation 9.91M5.19M16.11M26.17M31.70M42.60M
Deferred Taxes -85.94M-13.42M-29.30M
Gains from Sales and Divestitures 0.03M0.14M
Gains from Investment Securities 2.38M5.21M5.72M6.46M6.32M7.16M
Non-cash Items 4.42M
Cash from Operations -75.44M-2.98M98.56M144.47M219.39M219.82M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 2.81M9.84M18.42M22.97M23.84M23.84M
Amortization of Deferred Charges 2.54M2.41M2.24M1.66M
Depreciation & Amortization (CF) 0.40M0.39M0.42M0.42M0.51M0.27M
Change in Working Capital
Change in Receivables 4.25M17.92M12.67M19.90M19.40M8.89M
Change in Inventory 1.09M2.73M0.61M-0.14M1.07M1.83M
Change in Account Payables 4.90M-3.80M-1.55M2.79M8.95M-5.38M
Change in Accured Expenses 7.76M18.45M17.26M20.42M46.48M11.80M
Other Working Capital Changes -1.47M5.77M1.66M7.55M-0.07M3.01M
Investing Activities
Capital Expenditures 0.15M0.00M0.30M0.17M0.31M1.15M
Change in Intangibles 75.00M
Acquisitions 36.97M
Change in Acquisitions & Divestments 9.07M118.31M98.53M
Cash from Investing Activities -127.15M-2.00M-100.30M-141.83M-46.44M-67.48M
Financing Activities
Other financing activities 5.18M5.80M9.15M3.00M
Cash from Financing Activities 143.77M209.16M7.42M6.84M-105.55M-11.00M
Additional items
Change in Cash -58.82M204.17M5.68M9.47M67.40M141.34M
Free Cash Flow -75.58M-2.99M98.26M144.29M219.07M218.67M
Net Cash Flow -58.82M204.17M5.68M9.47M67.40M141.34M